This is a public record generated listing.
Assets of New Jersey Pharmaceutical Company
Listing Information
Attachments
Assets of New Jersey Pharmaceutical Company
Price: $64,000,000.00
Other Item Info
Item #: debke_186290
Created: 11/26/2021
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: New York, New York
Sale Date: Thu. Jan 13, 2022
Created: 11/26/2021
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: New York, New York
Sale Date: Thu. Jan 13, 2022
Seller Info
Matthew B. Lunn
Debtor's Attorney
1270 Avenue of the Americas, Suite 2210
New York, NY 10020
Debtor's Attorney
1270 Avenue of the Americas, Suite 2210
New York, NY 10020
Bankruptcy Info
Case #: 1:21-bk-11332
Case Title: Teligent, Inc.
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Case Title: Teligent, Inc.
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Description
Sale of assets of Teligent, Inc. which includes:
- the Facility for $27 million
- the Canadian Assets for $30 million
- the U.S. Marketing Authorizations for $7 million
Assets for sale is more described in attached PDF.
Financial Overview
Income and Expenses ($)
months
Revenue/Gross Income:
Total Expenses:
Cash Flow:
Asset and Liability Summary ($)
Receivables:
Inventory:
FF&E:
Real Estate:
Total Assets:
Liabilities to assume:
Additional Details
Auction time: 10:00 a.m.
Sale hearing on January 18, 2022 at 10:00 a.m.
Minimum bid: $28,060,000 in cash for the Facility, $31,650,000 in cash for the Canadian Assets and $7,580,000 in cash for the U.S. Marketing Authorizations.
Bid increment: $250,000 for the Facility, $250,000 for the Canadian Assets and $250,000 for the U.S. Marketing Authorizations
Bid deposit: 10% of the Purchase Price of the Bid
Bid deadline: January 11, 2022
Last date to respond: 14 days from the date of service
Date of service: November 24, 2021